who owns glp 1 drugs The Next Big Weight Loss Drug Stocks How Employers Can Manage GLP-1

[DOI] [PubMed] [Google Scholar] 88.Anti-inflammatory effects of GLP-1-based therapies beyond glucose control

GLP-1 medications and our comprehensive weight loss programs can give you the tools and support you need to succeed

The study, conducted using electronic health records from the TriNetX network between 2017 and 2024, excluded patients with prior neurodegenerative or cerebrovascular conditions and used propensity score matching to balance baseline characteristics

This is called telogen effluvium (TE)

Eli Lilly has been aggressively taking market share from Novo Nordisk over the past two years and, according to Bloomberg estimates, is expected to continue doing so through the first half of 2026

For now, it serves as a reminder that healthcare is not one-size-fits-all, and even small adjustments may have significant impacts